Global Blood Therapeutics Inc. (GBT)

56.14
0.12 0.21
NASDAQ : Health Technology
Prev Close 56.02
Open 56.56
Day Low/High 55.13 / 57.50
52 Wk Low/High 30.15 / 64.94
Volume 1.25M
Avg Volume 787.00K
Exchange NASDAQ
Shares Outstanding 60.23M
Market Cap 3.33B
EPS -3.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
Global Blood Therapeutics Makes a Bold Move

Global Blood Therapeutics Makes a Bold Move

This stock's old highs may come into play.

Chart of the Day: Global Blood Therapeutics

This stock's old highs may come into play.

Biotech Names Flexing Their Muscles

Biotech Names Flexing Their Muscles

There's action in Global Blood Therapeutics and Antares Pharma.

GUERBET : 2017 Half-year Results

GUERBET : 2017 Half-year Results

Hoping for Negative Seasonality, but Market's Not Holding Its Breadth

Hoping for Negative Seasonality, but Market's Not Holding Its Breadth

The major indices barely budged intraday this week, as we had the narrowest trading range ever.

GUERBET : Revenue At June 30, 2017

GUERBET : Revenue At June 30, 2017

First Week of GBT March 2018 Options Trading

First Week of GBT March 2018 Options Trading

Investors in Global Blood Therapeutics Inc saw new options begin trading this week, for the March 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Global Blood Shares Pop on Priority Designation; Kite Pharma Rises on Patent News: Biotech Movers

Global Blood Shares Pop on Priority Designation; Kite Pharma Rises on Patent News: Biotech Movers

Global Blood Therapeutics, Kite Pharma and Bellicum Pharmaceuticals were among the biotech movers in premarket trading on June 28.

Russell Rebalancing Tops Off a Choppy Week

Russell Rebalancing Tops Off a Choppy Week

It's hard to be too negative considering the speculative action today.

First Week of August 18th Options Trading For Global Blood Therapeutics (GBT)

Investors in Global Blood Therapeutics Inc saw new options become available this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GBT options chain for the new August 18th contracts and identified one put and one call contract of particular interest.

GUERBET : 1st Quarter 2017 Revenue

First Week of GBT December 15th Options Trading

Investors in Global Blood Therapeutics Inc saw new options begin trading this week, for the December 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

GUERBET : 2016 Annual Results